A leucine‐rich repeat kinase 2 (LRRK2) pathway biomarker characterization study in patients with Parkinson's disease with and without LRRK2 mutations and healthy controls

Abstract Increased leucine‐rich repeat kinase 2 (LRRK2) kinase activity is an established risk factor for Parkinson's disease (PD), and several LRRK2 kinase inhibitors are in clinical development as potential novel disease‐modifying therapeutics. This biomarker characterization study explored w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maurits F. J. M. Vissers (Autor), Matthew D. Troyer (Autor), Eva Thijssen (Autor), Diana R. Pereira (Autor), | Jules A. A. C. Heuberger (Autor), Geert Jan Groeneveld (Autor), Sarah Huntwork‐Rodriguez (Autor)
Formato: Libro
Publicado: Wiley, 2023-08-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible